Your browser doesn't support javascript.
loading
Blocking the PD-1-PD-L1 axis by a novel PD-1 specific nanobody expressed in yeast as a potential therapeutic for immunotherapy.
Xian, Zongshu; Ma, Linlin; Zhu, Min; Li, Guanghui; Gai, Junwei; Chang, Qing; Huang, Yuliang; Ju, Dianwen; Wan, Yakun.
Afiliación
  • Xian Z; School of Pharmacy, Fudan University, Shanghai, China.
  • Ma L; Jiading Distinct Central Hospital Affiliated Shanghai University of Medicine and Health Sciences, Shanghai, China.
  • Zhu M; Shanghai Novamab Biopharmaceuticals Co., Ltd., Shanghai, China.
  • Li G; Shanghai Novamab Biopharmaceuticals Co., Ltd., Shanghai, China.
  • Gai J; Shanghai Novamab Biopharmaceuticals Co., Ltd., Shanghai, China.
  • Chang Q; Jiading Distinct Central Hospital Affiliated Shanghai University of Medicine and Health Sciences, Shanghai, China.
  • Huang Y; School of Pharmacy, Fudan University, Shanghai, China.
  • Ju D; School of Pharmacy, Fudan University, Shanghai, China. Electronic address: dianwenju@fudan.edu.cn.
  • Wan Y; Shanghai Novamab Biopharmaceuticals Co., Ltd., Shanghai, China. Electronic address: ykwan@novamab.com.
Biochem Biophys Res Commun ; 519(2): 267-273, 2019 11 05.
Article en En | MEDLINE | ID: mdl-31495493
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Saccharomyces cerevisiae / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Anticuerpos de Dominio Único / Inmunoterapia Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Saccharomyces cerevisiae / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Anticuerpos de Dominio Único / Inmunoterapia Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article